Report #2826023

Received Feb 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: Jan 1, 2025
Onset: Jan 1, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Fatigue

Symptom narrative

tiredness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a female patient who received Herpes zoster (Shingrix) for prophylaxis. In JAN-2025, the patient received the 1st dose of Shingrix. In JAN-2025, 1 day after receiving Shingrix, the patient experienced tiredness (Verbatim: tiredness). The outcome of the tiredness was resolved. It was unknown if the reporter considered the tiredness to be related to Shingrix. It was unknown if the company considered the tiredness to be related to Shingrix. Additional Information: GSK Receipt Date: 07-FEB-2025 This case was reported by a patient via interactive digital media. The reporter reported that she was vaccinated for the first of two shingles vaccines a couple of weeks ago. The only issue she had was tiredness the following day.